Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 237.35 INR
Change Today -8.65 / -3.52%
Volume 281.6K
ASTEL On Other Exchanges
Symbol
Exchange
Natl India
As of 4:44 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

astec lifesciences ltd (ASTEL) Snapshot

Open
244.50
Previous Close
246.00
Day High
247.30
Day Low
236.50
52 Week High
07/21/15 - 304.00
52 Week Low
09/5/14 - 62.95
Market Cap
4.6B
Average Volume 10 Days
360.2K
EPS TTM
7.78
Shares Outstanding
19.5M
EX-Date
09/15/15
P/E TM
30.5x
Dividend
1.25
Dividend Yield
0.42%
Current Stock Chart for ASTEC LIFESCIENCES LTD (ASTEL)

Related News

No related news articles were found.

astec lifesciences ltd (ASTEL) Related Businessweek News

No Related Businessweek News Found

astec lifesciences ltd (ASTEL) Details

Astec LifeSciences Limited manufactures of agrochemicals and pharmaceutical intermediates in India. The company offers agrochemicals, such as tebuconazole, propiconazole, hexaconazole, difenoconazole, epoxiconazole, cyproconazole, flutriafol, tricyclazole, metalaxyl, and lambda cyhalothrin; and pharmaceutical intermediates, including 2’,4’-dichloroacetophenone, 2-chloro-4’-fluoro acetophenone, 4-methyl phthalic anhydride, and thio bis-4-chloro thymol. It is also involved in the sale of approximately 30 branded formulations that primarily comprise fungicides, herbicides, and insecticides. The company also serves customers in the Americas, Europe, Africa, the Middle East, and the Asia Pacific. Astec LifeSciences Limited was founded in 1994 and is based in Mumbai, India.

Founded in 1994

astec lifesciences ltd (ASTEL) Top Compensated Officers

Chairman, Managing Director and Member of Ris...
Total Annual Compensation: 4.8M
Whole Time Director
Total Annual Compensation: 944.0K
Compensation as of Fiscal Year 2014.

astec lifesciences ltd (ASTEL) Key Developments

Astec Lifesciences Limited Reports Unaudited Consolidated and Standalone Earnings Results for the First Quarter Ended June 30, 2015

Astec LifeSciences Limited reported unaudited consolidated and standalone earnings results for the first quarter ended June 30, 2015. For the quarter, on standalone basis, the company reported total income from operations (net of excise duty) of INR 544.224 million compared to INR 489.155 million a year ago. Profit from operations before other income, interest & exceptional items was INR 75.788 million compared to INR 55.023 million a year ago. Profit from ordinary activities before tax was INR 36.014 million compared to INR 31.390 million a year ago. Net profit was INR 311.195 million or INR 1.60 per basic and diluted share compared to INR 24.143 million or INR 1.30 per basic and diluted share for the last year. For the quarter, on consolidated basis, the company reported total income from operations (net of excise duty) of INR 572.258 million compared to INR 509.287 million a year ago. Profit from operations before other income, interest & exceptional items was INR 72.871 million compared to INR 51.897 million a year ago. Profit from ordinary activities before tax was INR 31.753 million compared to INR 25.320 million a year ago. Net profit of INR 26.861 million or INR 1.38 per basic and diluted share compared to INR 18.057 million or INR 0.97 per basic and diluted share for the last year.

Astec LifeSciences Limited, Board Meeting, Jul 25, 2015

Astec LifeSciences Limited, Board Meeting, Jul 25, 2015. Agenda: To consider and approve the unaudited financial results of the company for the quarter ended June 30, 2015 after these results are reviewed by the Audit Committee.

Astec LifeSciences Limited to Report Q1, 2016 Results on Jul 25, 2015

Astec LifeSciences Limited announced that they will report Q1, 2016 results on Jul 25, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ASTEL:IN 237.35 INR -8.65

ASTEL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ASTEL.
View Industry Companies
 

Industry Analysis

ASTEL

Industry Average

Valuation ASTEL Industry Range
Price/Earnings 47.9x
Price/Sales 1.7x
Price/Book 3.2x
Price/Cash Flow 16.4x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTEC LIFESCIENCES LTD, please visit www.astecls.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.